A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-21
DOI
10.1186/s13045-020-00959-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myeloma
- (2020) Lijie Xing et al. LEUKEMIA
- Increased HDAC Activity and c-MYC Expression Mediate Acquired Resistance to WEE1 Inhibition in Acute Leukemia
- (2020) Tamara B. Garcia et al. Frontiers in Oncology
- WEE1 inhibition synergizes with CHOP chemotherapy and radiation therapy through induction of premature mitotic entry and DNA damage in diffuse large B-cell lymphoma
- (2020) Mathilde R. W. de Jong et al. Therapeutic Advances in Hematology
- Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer
- (2020) Todd M. Pitts et al. Cancers
- Inhibiting Wee1 and ATR kinases produces tumor-selective synthetic lethality and suppresses metastasis
- (2019) Amirali B. Bukhari et al. JOURNAL OF CLINICAL INVESTIGATION
- Combined Aurora kinase A (AURKA) and WEE1 inhibition demonstrates synergistic antitumor effect in squamous cell carcinoma of the head and neck
- (2019) Jong Woo Lee et al. CLINICAL CANCER RESEARCH
- Time dependent response of daunorubicin on cytotoxicity, cell cycle and DNA repair in acute lymphoblastic leukaemia
- (2019) Hussain Mubarak Al-Aamri et al. BMC CANCER
- Differential activity of ATR and WEE1 inhibitors in a highly sensitive subpopulation of DLBCL linked to replication stress
- (2019) Lucy A. Young et al. CANCER RESEARCH
- Sulfur Mustard Analog Mechlorethamine (Bis(2-chloroethyl)methylamine) Modulates Cell Cycle Progression via the DNA Damage Response in Human Lung Epithelial A549 Cells
- (2019) Yi-Hua Jan et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Adavosertib with chemotherapy (CT) in patients (pts) with platinum-resistant ovarian cancer (PPROC): An open label, four-arm, phase II study.
- (2019) Kathleen N. Moore et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA damage response inhibitor combinations exert synergistic antitumor activity in aggressive B cell lymphomas
- (2019) Valentina Restelli et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of Wee1 sensitizes AML cells to ATR inhibitor VE-822-induced DNA damage and apoptosis
- (2019) Wenxiu Qi et al. BIOCHEMICAL PHARMACOLOGY
- Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy
- (2019) Yong Fang et al. CANCER CELL
- Effects of MCRS1 on proliferation, migration, invasion, and epithelial mesenchymal transition of gastric cancer cells by interacting with Pkmyt1 protein kinase
- (2019) Xin-Meng Wang et al. CELLULAR SIGNALLING
- Bromodomain and Extraterminal Domain Inhibition Synergizes with WEE1‐Inhibitor AZD1775 Effect by Impairing Non‐Homologous End Joining and Enhancing DNA Damage in Non‐Small Cell Lung Cancer
- (2019) Yuta Takashima et al. INTERNATIONAL JOURNAL OF CANCER
- Overexpressed PKMYT1 promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma
- (2019) Qingyi Zhang et al. Cancer Management and Research
- Sequential combination of bortezomib and WEE1 inhibitor, MK-1775, induced apoptosis in multiple myeloma cell lines
- (2019) Rebecca S.S. Barbosa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- DNA Damage Repair Interference By WEE1 Inhibition with AZD1775 Overcomes Combined Azacitidine and Venetoclax Resistance in Acute Myeloid Leukmeia (AML)
- (2019) Raoul Tibes et al. BLOOD
- Upregulation of Myt1 Promotes Acquired Resistance of Cancer Cells to Wee1 Inhibition
- (2019) Cody W. Lewis et al. CANCER RESEARCH
- The balance between mitotic death and mitotic slippage in acute leukemia: a new therapeutic window?
- (2019) Andrea Ghelli Luserna di Rorà et al. Journal of Hematology & Oncology
- PKMYT1: a forgotten member of the WEE1 family
- (2019) Christopher R. M. Asquith et al. NATURE REVIEWS DRUG DISCOVERY
- Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer
- (2019) Yoo-Young Lee et al. Scientific Reports
- Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia
- (2019) Ghelli Luserna Di Rorà et al. Cancers
- WEE1 Inhibition Enhances Anti-Apoptotic Dependency as a Result of Premature Mitotic Entry and DNA Damage
- (2019) Mathilde Rikje Willemijn de Jong et al. Cancers
- Systematic expression analysis of WEE family kinases reveals the importance of PKMYT1 in breast carcinogenesis
- (2019) Yu Liu et al. CELL PROLIFERATION
- Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with Gemcitabine
- (2018) Siang-Boon Koh et al. CANCER RESEARCH
- The combination of the PARP inhibitor olaparib and the Wee1 inhibitor AZD1775 as a new therapeutic option for small cell lung cancer
- (2018) Alice Lallo et al. CLINICAL CANCER RESEARCH
- A Phase I Clinical Trial of AZD1775 in Combination with Neoadjuvant Weekly Docetaxel and Cisplatin before Definitive Therapy in Head and Neck Squamous Cell Carcinoma
- (2018) Eduardo Méndez et al. CLINICAL CANCER RESEARCH
- Whole-Genome Expression Microarray Combined with Machine Learning to Identify Prognostic Biomarkers for High-Grade Glioma
- (2018) Chang Shu et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Increased activity of both CDK1 and CDK2 is necessary for the combinatorial activity of WEE1 inhibition and cytarabine
- (2018) Tamara B. Garcia et al. LEUKEMIA RESEARCH
- Proteomics Profiling of CLL Versus Healthy B-cells Identifies Putative Therapeutic Targets and a Subtype-independent Signature of Spliceosome Dysregulation
- (2018) Harvey E. Johnston et al. MOLECULAR & CELLULAR PROTEOMICS
- Targeting the replication stress response in cancer
- (2018) Josep V. Forment et al. PHARMACOLOGY & THERAPEUTICS
- Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach
- (2018) Mathilde R. W. de Jong et al. PLoS One
- ATR/CHK1 inhibitors and cancer therapy
- (2018) Zhaojun Qiu et al. RADIOTHERAPY AND ONCOLOGY
- Combined Inhibition of ATR and WEE1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
- (2018) Juan Jin et al. NEOPLASIA
- Nucleolar integrity during interphase supports faithful Cdk1 activation and mitotic entry
- (2018) Yuki Hayashi et al. Science Advances
- Combination of lutetium-177 labelled anti-L1CAM antibody chCE7 with the clinically relevant protein kinase inhibitor MK1775: a novel combination against human ovarian carcinoma
- (2018) Dennis Lindenblatt et al. BMC CANCER
- Strategic development of AZD1775, a Wee1 kinase inhibitor, for cancer therapy
- (2018) Siqing Fu et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The Role of Tumor Microenvironment in Chemoresistance: 3D Extracellular Matrices as Accomplices
- (2018) Dimakatso Senthebane et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
- (2018) Andrea Ghelli Luserna Di Rorà et al. Journal of Hematology & Oncology
- Premature activation of Cdk1 leads to mitotic events in S phase and embryonic lethality
- (2018) Radoslaw Szmyd et al. ONCOGENE
- Fighting tubulin-targeting anticancer drug toxicity and resistance
- (2017) Roberta Visconti et al. ENDOCRINE-RELATED CANCER
- PKMYT1 promoted the growth and motility of hepatocellular carcinoma cells by activating beta-catenin/TCF signaling
- (2017) Lei Liu et al. EXPERIMENTAL CELL RESEARCH
- The cell cycle checkpoint inhibitors in the treatment of leukemias
- (2017) A. Ghelli Luserna di Rora’ et al. Journal of Hematology & Oncology
- Structural Basis of Wee Kinases Functionality and Inactivation by Diverse Small Molecule Inhibitors
- (2017) Jin-Yi Zhu et al. JOURNAL OF MEDICINAL CHEMISTRY
- PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP Inhibitors
- (2017) Leslie A. Parsels et al. MOLECULAR CANCER RESEARCH
- A Small-Molecule Inhibitor of WEE1, AZD1775, Synergizes with Olaparib by Impairing Homologous Recombination and Enhancing DNA Damage and Apoptosis in Acute Leukemia
- (2017) Tamara B. Garcia et al. MOLECULAR CANCER THERAPEUTICS
- CDK4/6 Inhibitors Sensitize Rb-positive Sarcoma Cells to Wee1 Kinase Inhibition through Reversible Cell-Cycle Arrest
- (2017) Ashleigh M. Francis et al. MOLECULAR CANCER THERAPEUTICS
- Regulation of G2/M Transition by Inhibition of WEE1 and PKMYT1 Kinases
- (2017) et al. MOLECULES
- Suppression of Sirt1 sensitizes lung cancer cells to WEE1 inhibitor MK-1775-induced DNA damage and apoptosis
- (2017) G Chen et al. ONCOGENE
- Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest
- (2017) Navin Sarin et al. PLoS One
- Prolonged mitotic arrest induced by Wee1 inhibition sensitizes breast cancer cells to paclitaxel
- (2017) Cody W. Lewis et al. Oncotarget
- Mutational status of TP53 defines the efficacy of Wee1 inhibitor AZD1775 in KRAS-mutant non-small cell lung cancer
- (2017) Bo Mi Ku et al. Oncotarget
- Dietary polyphenols influence antimetabolite agents: methotrexate, 6-mercaptopurine and 5-fluorouracil in leukemia cell lines
- (2017) Amani Mahbub et al. Oncotarget
- Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway
- (2017) Santosh Kumar Singh et al. Oncotarget
- WEE1 inhibition targets cell cycle checkpoints for triple negative breast cancers to overcome cisplatin resistance
- (2017) Hongping Zheng et al. Scientific Reports
- Mechanisms responsible for the synergistic antileukemic interactions between ATR inhibition and cytarabine in acute myeloid leukemia cells
- (2017) Jun Ma et al. Scientific Reports
- Inhibition of CHK1 and WEE1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulation
- (2016) Valentina Restelli et al. BRITISH JOURNAL OF HAEMATOLOGY
- Identification of clinically achievable combination therapies in childhood rhabdomyosarcoma
- (2016) Elliot Kahen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A Mechanism for Controlled Breakage of Under-replicated Chromosomes during Mitosis
- (2016) Heike Duda et al. DEVELOPMENTAL CELL
- Phase II Study of WEE1 Inhibitor AZD1775 Plus Carboplatin in Patients With TP53-Mutated Ovarian Cancer Refractory or Resistant to First-Line Therapy Within 3 Months
- (2016) Suzanne Leijen et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study Evaluating WEE1 Inhibitor AZD1775 As Monotherapy and in Combination With Gemcitabine, Cisplatin, or Carboplatin in Patients With Advanced Solid Tumors
- (2016) Suzanne Leijen et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression and prognostic value of the WEE1 kinase in gliomas
- (2016) Darija Music et al. JOURNAL OF NEURO-ONCOLOGY
- BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma
- (2016) E.M. Novak et al. MEDICAL HYPOTHESES
- ATM Expression Predicts Veliparib and Irinotecan Sensitivity in Gastric Cancer by Mediating P53-Independent Regulation of Cell Cycle and Apoptosis
- (2016) Vinod Vijay Subhash et al. MOLECULAR CANCER THERAPEUTICS
- PTEN enhances G2/M arrest in etoposide-treated MCF-7 cells through activation of the ATM pathway
- (2016) RUOPENG ZHANG et al. ONCOLOGY REPORTS
- Errata
- (2016) RADIATION RESEARCH
- Expression and clinical significance of Wee1 in colorectal cancer
- (2016) Eivind Valen Egeland et al. TUMOR BIOLOGY
- Targeting the WEE1 kinase as a molecular targeted therapy for gastric cancer
- (2016) Hye-Young Kim et al. Oncotarget
- WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner
- (2016) Shruti Lal et al. Scientific Reports
- Synergistic anti-leukemic interactions between panobinostat and MK-1775 in acute myeloid leukemia ex vivo
- (2015) Wenxiu Qi et al. CANCER BIOLOGY & THERAPY
- The Fcp1-Wee1-Cdk1 axis affects spindle assembly checkpoint robustness and sensitivity to antimicrotubule cancer drugs
- (2015) R Visconti et al. CELL DEATH AND DIFFERENTIATION
- Chk1 and Wee1 control genotoxic-stress induced G2–M arrest in melanoma cells
- (2015) Julio Vera et al. CELLULAR SIGNALLING
- Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors
- (2015) Khanh Do et al. JOURNAL OF CLINICAL ONCOLOGY
- Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736
- (2015) Valentina Restelli et al. Oncotarget
- AZD1775 sensitizes T cell acute lymphoblastic leukemia cells to cytarabine by promoting apoptosis over DNA repair
- (2015) James B. Ford et al. Oncotarget
- Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma
- (2015) Rosaria Chilà et al. Oncotarget
- Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1
- (2014) Lei Duan et al. CANCER BIOLOGY & THERAPY
- Re-purposing clinical kinase inhibitors to enhance chemosensitivity by overriding checkpoints
- (2014) Neil Beeharry et al. CELL CYCLE
- CHK It Out! Blocking WEE Kinase Routs TP53 Mutant Cancer
- (2014) J. E. Bauman et al. CLINICAL CANCER RESEARCH
- 988 Sequence Alterations in the WEE1 Non-Coding Region Is a Facilitator and Marker for Pancreatic Tumorigenesis
- (2014) Shruti Lal et al. GASTROENTEROLOGY
- Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions
- (2014) Ana Slipicevic et al. GYNECOLOGIC ONCOLOGY
- Habiterpenol, a novel abrogator of bleomycin-induced G2 arrest in Jurkat cells, produced by Phytohabitans suffuscus 3787_5
- (2014) Ryuji Uchida et al. JOURNAL OF ANTIBIOTICS
- Identification and Pharmacological Inactivation of the MYCN Gene Network as a Therapeutic Strategy for Neuroblastic Tumor Cells
- (2014) Olesya Chayka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CHK1 plays a critical role in the anti-leukemic activity of the wee1 inhibitor MK-1775 in acute myeloid leukemia cells
- (2014) Wenxiu Qi et al. Journal of Hematology & Oncology
- A regimen combining the Wee1 inhibitor AZD1775 with HDAC inhibitors targets human acute myeloid leukemia cells harboring various genetic mutations
- (2014) L Zhou et al. LEUKEMIA
- Identification of Wee1 as a novel therapeutic target for mutant RAS-driven acute leukemia and other malignancies
- (2014) E Weisberg et al. LEUKEMIA
- Computational analysis of image-based drug profiling predicts synergistic drug combinations: Applications in triple-negative breast cancer
- (2014) Miriam B. Brandl et al. Molecular Oncology
- WEE1 murine deficiency induces hyper-activation of APC/C and results in genomic instability and carcinogenesis
- (2014) A Vassilopoulos et al. ONCOGENE
- Targeting the wee1 kinase for treatment of pediatric Down syndrome acute myeloid leukemia
- (2014) J. Timothy Caldwell et al. PEDIATRIC BLOOD & CANCER
- Pemetrexed Induces S-Phase Arrest and Apoptosis via a Deregulated Activation of Akt Signaling Pathway
- (2014) Kun-Chieh Chen et al. PLoS One
- Vitamin C Effect on Mitoxantrone-Induced Cytotoxicity in Human Breast Cancer Cell Lines
- (2014) Eliana Guerriero et al. PLoS One
- Synergy of 1,25-dihydroxyvitamin D3 and carboplatin in growth suppression of SKOV-3 cells
- (2014) ZENGLI ZHANG et al. Oncology Letters
- CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo
- (2013) L. Chaudhuri et al. HAEMATOLOGICA
- Combination Drug Scheduling Defines a "Window of Opportunity" for Chemopotentiation of Gemcitabine by an Orally Bioavailable, Selective ChK1 Inhibitor, GNE-900
- (2013) E. Blackwood et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of Wee1 Sensitizes Cancer Cells to Antimetabolite Chemotherapeutics In Vitro and In Vivo, Independent of p53 Functionality
- (2013) A. A. Van Linden et al. MOLECULAR CANCER THERAPEUTICS
- Emerging landscape of oncogenic signatures across human cancers
- (2013) Giovanni Ciriello et al. NATURE GENETICS
- Targeting Wee1 for the treatment of pediatric high-grade gliomas
- (2013) Sabine Mueller et al. NEURO-ONCOLOGY
- Wee1 Inhibition by MK-1775 Leads to Tumor Inhibition and Enhances Efficacy of Gemcitabine in Human Sarcomas
- (2013) Jenny M. Kreahling et al. PLoS One
- RNAi screening of the kinome with cytarabine in leukemias
- (2012) R. Tibes et al. BLOOD
- The end of mitosis from a phosphatase perspective
- (2012) Roberta Visconti et al. CELL CYCLE
- Vincristine induces cell cycle arrest and apoptosis in SH-SY5Y human neuroblastoma cells
- (2012) YUE TU et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia
- (2012) C C Porter et al. LEUKEMIA
- WEE1 Kinase Inhibition Enhances the Radiation Response of Diffuse Intrinsic Pontine Gliomas
- (2012) V. Caretti et al. MOLECULAR CANCER THERAPEUTICS
- Structural and Spectroscopic Analysis of the Kinase Inhibitor Bosutinib and an Isomer of Bosutinib Binding to the Abl Tyrosine Kinase Domain
- (2012) Nicholas M. Levinson et al. PLoS One
- High Expression of Wee1 Is Associated with Poor Disease-Free Survival in Malignant Melanoma: Potential for Targeted Therapy
- (2012) Gry Irene Magnussen et al. PLoS One
- Fcp1-dependent dephosphorylation is required for M-phase-promoting factor inactivation at mitosis exit
- (2012) Roberta Visconti et al. Nature Communications
- Forced Mitotic Entry of S-Phase Cells as a Therapeutic Strategy Induced by Inhibition of WEE1
- (2012) Marieke Aarts et al. Cancer Discovery
- WEE1 inhibition sensitizes osteosarcoma to radiotherapy
- (2011) Jantine PosthumaDeBoer et al. BMC CANCER
- Eukaryotic Origin-Dependent DNA Replication In Vitro Reveals Sequential Action of DDK and S-CDK Kinases
- (2011) Ryan C. Heller et al. CELL
- Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agent
- (2011) Diana Nguyen et al. CELL CYCLE
- MK-1775, a Potent Wee1 Inhibitor, Synergizes with Gemcitabine to Achieve Tumor Regressions, Selectively in p53-Deficient Pancreatic Cancer Xenografts
- (2011) N. V. Rajeshkumar et al. CLINICAL CANCER RESEARCH
- MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
- (2011) K. A. Bridges et al. CLINICAL CANCER RESEARCH
- Wee1 controls genomic stability during replication by regulating the Mus81-Eme1 endonuclease
- (2011) Raquel Domínguez-Kelly et al. JOURNAL OF CELL BIOLOGY
- Modulation of anthracycline-induced cytotoxicity by targeting the prenylated proteome in myeloid leukemia cells
- (2011) Michael A. Morgan et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Tyrosine kinase receptor inhibitor-targeted combined chemotherapy for metastatic bladder cancer
- (2011) Chia-Lun Wu et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Inhibitory Phosphorylation of Cyclin-Dependent Kinase 1 as a Compensatory Mechanism for Mitosis Exit
- (2011) J. P. H. Chow et al. MOLECULAR AND CELLULAR BIOLOGY
- Replication Stress Induces Micronuclei Comprising of Aggregated DNA Double-Strand Breaks
- (2011) Bing Xu et al. PLoS One
- Novel insights into maintaining genomic integrity: Wee1 regulating Mus81/Eme1
- (2011) Yusé Martín et al. Cell Division
- Cells expressing FLT3/ITD mutations exhibit elevated repair errors generated through alternative NHEJ pathways: implications for genomic instability and therapy
- (2010) J. Fan et al. BLOOD
- MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil
- (2010) Hiroshi Hirai et al. CANCER BIOLOGY & THERAPY
- In Silico Analysis of Kinase Expression Identifies WEE1 as a Gatekeeper against Mitotic Catastrophe in Glioblastoma
- (2010) Shahryar E. Mir et al. CANCER CELL
- Actinomycin D Decreases Mcl-1 Expression and Acts Synergistically with ABT-737 against Small Cell Lung Cancer Cell Lines
- (2010) H. Xu et al. CLINICAL CANCER RESEARCH
- How do Cdc7 and cyclin-dependent kinases trigger the initiation of chromosome replication in eukaryotic cells?
- (2010) K. Labib GENES & DEVELOPMENT
- Methotrexate, Paclitaxel, and Doxorubicin Radiosensitize HER2-Amplified Human Breast Cancer Cells to the Auger Electron-Emitting Radiotherapeutic Agent 111In-NLS-Trastuzumab
- (2010) D. L. Costantini et al. JOURNAL OF NUCLEAR MEDICINE
- Prophase I arrest and progression to metaphase I in mouse oocytes: comparison of resumption of meiosis and recovery from G2-arrest in somatic cells
- (2010) P. Solc et al. MOLECULAR HUMAN REPRODUCTION
- Myt1 protein kinase is essential for Golgi and ER assembly during mitotic exit
- (2008) Hiroyuki Nakajima et al. JOURNAL OF CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started